Sfoglia per Autore

opzioni
Mostrati risultati da 21 a 40 di 97
Titolo Data di pubblicazione Autore(i) File
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts 1-gen-2012 Porru, M; Zappavigna, S; Luce, A; Panico, A; Salzano, G; Lusa, S; De Rosa, G; Leonetti, C; Caraglia, Michele
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. 1-gen-2012 Marra, M; Salzano, G; Leonetti, C; Porru, M; Franco, Renato; Zappavigna, S; Liguori, G; Botti, G; Chieffi, Paolo; Lamberti, Monica; Vitale, G; Abbruzzese, A; La Rotonda, Mi; De Rosa, G; Caraglia, Michele
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. 1-gen-2012 Vitale, G; Zappavigna, S; Marra, M; Dicitore, A; Meschini, S; Condello, M; Arancia, G; Castiglioni, S; Maroni, P; Bendinelli, P; Piccoletti, R; van Koetsveld, Pm; Cavagnini, F; Budillon, A; Abbruzzese, A; Hofland, Lj; Caraglia, Michele
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 1-gen-2012 Ferro, M; Giuberti, G; Zappavigna, S; Perdonà, S; Facchini, G; Sperlongano, Pasquale; Porto, S; Di Lorenzo, G; Buonerba, C; Abbruzzese, A; Altieri, V; Caraglia, Michele
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells. 1-gen-2012 Sanges, C; Scheuermann, C; Zahedi, Rp; Sickmann, A; Lamberti, A; Migliaccio, N; Baljuls, A; Marra, M; Zappavigna, S; Reinders, J; Rapp, U; Abbruzzese, A; Caraglia, Michele; Arcari, P.
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. 1-gen-2012 Lamberti, Monica; Porto, S; Marra, M; Zappavigna, S; Grimaldi, A; Feola, D; Pesce, D; Naviglio, Silvio; Spina, Annamaria; Sannolo, Nicola; Caraglia, Michele
Autophagic cell death: A new frontier in cancer research 1-gen-2013 Zappavigna, S.; Luce, A.; Vitale, G.; Merola, N.; Facchini, S.; Caraglia, M.
Nanoparticles releasing zoledronic acid have antitumor activity against experimental models of human glioblastoma 1-gen-2013 Leonetti, ; C, ; Porru, ; M, ; Artuso, ; S, ; Zappavigna, S; Luce, ; A, ; Salzano, ; G, ; Lusa, ; S, ; De, Rosa; G, ; Caraglia, ; M,
Interleukin 18: Friend or foe in cancer. 1-gen-2013 Palma, G; Barbieri, A; Bimonte, S; Palla, M; Zappavigna, S; Caraglia, Michele; Ascierto, Pa; Ciliberto, G; Arra, C.
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. 1-gen-2013 Addeo, R; Zappavigna, Silvia; Luce, Amalia; Facchini, S; Caraglia, Michele
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. 1-gen-2013 Caraglia, Michele; Luongo, Livio; Salzano, G; Zappavigna, S; Marra, M; Guida, Francesca; Lusa, S; Giordano, C; DE NOVELLIS, Vito; Rossi, Francesco; Abbruzzese Saccardi, A; De Rosa, G; Maione, Sabatino
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation 1-gen-2013 Perna, A; Sepe, I; Lanza, D; Capasso, R; Zappavigna, S; Capasso, G; Caraglia, M; Ingrosso, D.
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? 1-gen-2013 Dicitore, A; Caraglia, Michele; Colao, A; Zappavigna, S; Mari, D; Hofland, Lj; Persani, L; Vitale, G.
Emerging pathways as individualized therapeutic target of multiple myeloma. 1-gen-2013 Misso, Gabriella; Zappavigna, S; Castellano, M; De Rosa, G; Di Martino, Mt; Tagliaferri, P; Tassone, P; Caraglia, Michele
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance. 1-gen-2013 Troiani, Teresa; Zappavigna, S; Martinelli, Erika; Addeo, Sr; Stiuso, Paola; Ciardiello, Fortunato; Caraglia, Michele
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO 1-gen-2013 Luce, A; Zappavigna, S; Balestrieri, Maria Luisa; D'Onofrio, N; Porru, M; Salzano, G; Lusa, S; Leonetti, C; De Rosa, G; Caraglia, Michele
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 1-gen-2014 Federico, Alessandro; Zappavigna, S; Romano, Marco; Grieco, P; Luce, A; Marra, M; Gravina, Ag; Stiuso, Paola; D’Armiento, Fp; Vitale, G; Tuccillo, C; Novellino, E; Loguercio, Carmelina; Caraglia, Michele
A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives. 1-gen-2014 Lamberti, Monica; Porto, S; Zappavigna, S; Addeo, E; Marra, M; Miraglia, Nadia; Sannolo, Nicola; Vanacore, D; Stiuso, Paola; Caraglia, Michele
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. 1-gen-2014 Lamberti, Monica; Zappavigna, S; Sannolo, Nicola; Porto, S; Caraglia, Michele
Erlotinib: early clinical development in brain cancer. 1-gen-2014 Addeo, R; Zappavigna, S; Parlato, Ciro; Caraglia, Michele
Mostrati risultati da 21 a 40 di 97
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile